Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Quarterly results

Inhibrx, Inc. (INBX) Create: Alert

All | News | Filings
Date FiledTypeDescription
03/02/2023 4 Eckelman Brendan P. (Chief Scientific Officer) has filed a Form 4 on Inhibrx, Inc.
Txns: Sold 39,600 shares @ $24.2007, valued at $958.3k
Sold 400 shares @ $24.7075, valued at $9.9k
03/01/2023 4 Lappe Mark (CEO) has filed a Form 4 on Inhibrx, Inc.
Txns: Sold 60 shares @ $25.0208, valued at $1.5k
02/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/24/2023 4 Lappe Mark (CEO) has filed a Form 4 on Inhibrx, Inc.
Txns: Sold 21,665 shares @ $25.3572, valued at $549.4k
Sold 4,272 shares @ $25.71, valued at $109.8k
Sold 63 shares @ $26.1127, valued at $1.6k
01/23/2023 4 Kayyem Jon Faiz (Director) has filed a Form 4 on Inhibrx, Inc.
Txns: Sold 9,500 shares @ $25.2631, valued at $240k
01/04/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/22/2022 4 Kayyem Jon Faiz (Director) has filed a Form 4 on Inhibrx, Inc.
Txns: Sold 7,541 shares @ $26.8653, valued at $202.6k
Sold 1,959 shares @ $27.6099, valued at $54.1k
12/20/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/07/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/22/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/18/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/24/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/18/2022 4 Lappe Mark (CEO) has filed a Form 4 on Inhibrx, Inc.
Txns: Sold 8,981 shares @ $28.6626, valued at $257.4k
Sold 14,006 shares @ $29.9245, valued at $419.1k
Sold 2,892 shares @ $30.8055, valued at $89.1k
Sold 121 shares @ $31.5071, valued at $3.8k
10/12/2022 4 VIKING GLOBAL INVESTORS LP (10% Owner) has filed a Form 4 on Inhibrx, Inc.
Txns: Bought 1,000,000 shares @ $29.9999, valued at $30M
Bought 333,333 shares @ $29.9999, valued at $10M
10/05/2022 4 Eckelman Brendan P. (Chief Scientific Officer) has filed a Form 4 on Inhibrx, Inc.
Txns: Sold 1,448 shares @ $24.6688, valued at $35.7k
Sold 6,207 shares @ $26.0614, valued at $161.8k
Sold 11,136 shares @ $26.7764, valued at $298.2k
Sold 4,262 shares @ $27.7566, valued at $118.3k
Sold 5,954 shares @ $28.9713, valued at $172.5k
Sold 10,893 shares @ $29.6798, valued at $323.3k
Sold 100 shares @ $30.52, valued at $3.1k
09/14/2022 4 Eckelman Brendan P. (Chief Scientific Officer) has filed a Form 4 on Inhibrx, Inc.
Txns: Gifted 160,000 shares @ $0
Gifted 80,000 shares @ $0
Gifted 80,000 shares @ $0
09/07/2022 4 Eckelman Brendan P. (Chief Scientific Officer) has filed a Form 4 on Inhibrx, Inc.
Txns: Sold 37,507 shares @ $14.857, valued at $557.2k
Sold 2,493 shares @ $15.6567, valued at $39k
08/25/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/08/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/04/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/02/2022 4 Kayyem Jon Faiz (Director) has filed a Form 4 on Inhibrx, Inc.
Txns: Gifted 118,500 shares @ $0
Gifted 25,000 shares @ $0
07/08/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/26/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/26/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/26/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/26/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/07/2022 4 Eckelman Brendan P. (Chief Scientific Officer) has filed a Form 4 on Inhibrx, Inc.
Txns: Sold 400 shares @ $25.04, valued at $10k
01/25/2022 4 Deck Kelly (CFO) has filed a Form 4 on Inhibrx, Inc.
Txns: Granted 20,000 options to buy @ $34.16, valued at $683.2k
12/07/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/08/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/08/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy